COMPANY
Isoformix
NIH awards 4
- NIH award 1R43AG079709-01A1 FY2023: $384,767 awarded for that fiscal year; activity R43 (SBIR); PI NEDELKOV, DOBRIN; recipient as written: ISOFORMIX, INC., Sugar Land, TX. Clusterin glycosylation as diagnostic and pr source ↗
- NIH award 1R43GM143964-01A1 FY2022: $256,158 awarded for that fiscal year; activity R43 (SBIR); PI NEDELKOV, DOBRIN; recipient as written: ISOFORMIX, INC., Sugar Land, TX. Immunoplate-MALDI MS platform and assays source ↗
- NIH award 1R43AG069552-01A1 FY2020: $250,562 awarded for that fiscal year; activity R43 (SBIR); PI NEDELKOV, DOBRIN; recipient as written: ISOFORMIX, INC., Sugar Land, TX. ApoE isoform-specific glycosylation as diagn source ↗
- NIH award 1R43GM128459-01 FY2018: $153,545 awarded for that fiscal year; activity R43 (SBIR); PI NEDELKOV, DOBRIN; recipient as written: ISOFORMIX, INC., Sugar Land, TX. Clinical mass spectrometry test for apolipopro source ↗